Xenon Pharmaceuticals Inc. (XENE) insider trading
Xenon Pharmaceuticals Inc. insiders have made 2 open-market purchases worth $1.7M since Oct 1, 2026, by 2 different insiders. The latest: Thomas Patrick Kelly (CFO) bought $560k, filed Oct 1, 2026, scored 73 out of 100. The biggest: $1.1M by Ian Mortimer, filed Oct 1, 2026. 1 buy in the last year came within ten days of another insider's: a cluster, one of the stronger patterns in the research.
Follow XENE, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 1 Form 4 (opens sec.gov) |
Thomas Patrick KellyCFOCFO · 2 insiders buying · Near 52-week low | New position | 73 | $560k 15,000 at $37.32 |
−7.1% | waiting |
| Oct 1 Form 4 (opens sec.gov) |
Ian MortimerPresident · 2 insiders buyingPresident · 2 insiders buying · Near 52-week low | +151% stake | 72 | $1.1M 30,000 at $37.38 |
−7.1% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −7.1% (0% up, 2 measured).
Insiders who bought XENE
- Thomas Patrick Kelly CFO
- Ian Mortimer President
Questions
Are insiders buying XENE stock?
Yes. In the last 90 days, 2 open-market purchases were filed, worth $1.7M.
Who bought XENE stock most recently?
Thomas Patrick Kelly, CFO, bought 15,000 shares for $560k (Form 4 (opens sec.gov), filed Oct 1, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 1, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer